Johnson & Johnson reports robust quarter, but full-year earn

Johnson & Johnson reported robust growth in sales and earnings in its fourth quarter numbers on Tuesday, with sales rising 7.3% year-on-year to $21.4bn.

Related Keywords

Canada , Joaquin Duato , Joe Biden , Johnson , Abiomed , Inflation Reduction Act , Reports , Robust , Quarter , , Full Year , Earnings , Slip , Category All , Category Market Report , Category Company News , Category News And Announcements , Category International Companies , Category Market Pulse , Category Headline News , Category Sectorial Health Technology ,